Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

TEVA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 49
  • 0 comments

FDA approve DIFLUNISAL

Comment Full text

ANI PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 43
  • 0 comments

FDA approve TOLMETIN SODIUM

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 46
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

RISING

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 52
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

SUN PHARM INDUSTRIES

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 47
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

NOVAST LABS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 50
  • 0 comments

FDA approve ASPIRIN; CARISOPRODOL

Comment Full text

EPIC PHARMA LLC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 47
  • 0 comments

FDA approve ASPIRIN; OXYCODONE HYDROCHLORIDE

Comment Full text

SUN PHARM INDUSTRIES

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 52
  • 0 comments

FDA approve ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE

Comment Full text

NORVIUM BIOSCIENCE

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 48
  • 0 comments

FDA approve IBUPROFEN

Comment Full text

NORVIUM BIOSCIENCE

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 45
  • 0 comments

FDA approve IBUPROFEN

Comment Full text
  • Previous
  • 305
  • 306
  • 307
  • 308
  • 309
  • Next

Search

News categories

  • Technical Exchange News(11495)
  • Event(3357)
  • SEC News(215871)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137356)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin